Citation Impact
Citing Papers
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802
2012
Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma
2011 Science
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
2010
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
2009 Standout
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
2009
Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile
2008
Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity
2012
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
2011 Standout
Astrocytes: biology and pathology
2009 Standout
Adjuvant Whole Brain Radiotherapy: Strong Emotions Decide But Rational Studies Are Needed
2008
Genetics of adult glioma
2012
IDH1andIDH2Mutations in Gliomas
2009 Standout
The WHO Classification of Tumors of the Nervous System
2002 Standout
Primary central nervous system non-hodgkin's lymphoma: Survival advantages with combined initial therapy?
1995
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
2006 Standout
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
MRI features predict survival and molecular markers in diffuse lower-grade gliomas
2016
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
2006 Standout
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
2009 Standout
The future of high-grade glioma: Where we are and where are we going
2015
Advances in Radiation Therapy for Brain Tumors
2007
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
2006 Standout
Photodynamic therapy of high grade glioma – long term survival
2005
Neurocognitive Function of Patients with Brain Metastasis Who Received Either Whole Brain Radiotherapy Plus Stereotactic Radiosurgery or Radiosurgery Alone
2007
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas
2009
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
2009
Nomograms in oncology: more than meets the eye
2015 Standout
Glioblastoma and Other Malignant Gliomas
2013 Standout
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial
2005
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131
2015
BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas
2007
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma
2013
Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors
2013
Survival rates in patients with low‐grade glioma after intraoperative magnetic resonance image guidance
2005
A 31-Year-Old Woman With a Transformed Low-grade Glioma
2010
GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME
2008
PTEN Mutation, EGFR Amplification, and Outcome in Patients With Anaplastic Astrocytoma and Glioblastoma Multiforme
2001
Factors influencing survival in high-grade gliomas
2003
EXTENT OF SURGICAL RESECTION IS INDEPENDENTLY ASSOCIATED WITH SURVIVAL IN PATIENTS WITH HEMISPHERIC INFILTRATING LOW-GRADE GLIOMAS
2008
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2016 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Fractionated stereotactic radiotherapy in low-grade astrocytomas: Long-term outcome and prognostic factors
2003
Psychosocial and supportive-care needs in high-grade glioma
2008
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K
2014
Mechanisms of Disease: genetic predictors of response to treatment in brain tumors
2007
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force
2010
Radiation Dose–Volume Effects in the Brain
2010
The 2016 World Health Organization classification of tumours of the central nervous system
2018
Advances in the molecular genetics of gliomas — implications for classification and therapy
2016
MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma
2008
Anaplastic Oligodendroglioma and Oligoastrocytoma
2007
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
Medical management of patients with brain tumors
2006
Malignant Gliomas in Adults
2008 Standout
The basis for current treatment recommendations for malignant gliomas
1994
Validation and Predictive Power of Radiation Therapy Oncology Group (RTOG) Recursive Partitioning Analysis Classes for Malignant Glioma Patients: A Report Using RTOG 90-06☆
1998
Maximizing safe resection of low- and high-grade glioma
2016
Results of combined‐modality therapy for limited‐stage small cell lung carcinoma in the elderly
2005
Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life
2010
Photodynamic therapy of cancer: An update
2011 Standout
Risk factors for oligodendroglial tumors: A pooled international study
2010
Hyperglycemia is independently associated with post-operative function loss in patients with primary eloquent glioblastoma
2012
Primary brain tumours in adults
2003
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors
1999
Primary brain tumours in adults
2012 Standout
Radiation Dose–Volume Effects in the Heart
2010
A Network Model of a Cooperative Genetic Landscape in Brain Tumors
2009
Radiation response and survival time in patients with glioblastoma multiforme
1996
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
2009 Standout
Targeted Therapy for Malignant Glioma Patients: Lessons Learned and the Road Ahead
2009
Role of Radiation Therapy and Radiosurgery in Glioblastoma Multiforme
2003
The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme
2006
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
2007
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
2014
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up
2009
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
2009 Standout
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
2011
Genomic aberrations in 80 cases of primary glioblastoma multiforme: Pathogenetic heterogeneity and putative cytogenetic pathways
2009
Brain Tumors
2001 Standout
Diffusion Changes in a Tumor and Peritumoral Tissue After Stereotactic Irradiation for Brain Tumors
2006 StandoutNobel
Seizures and cancer: drug interactions of anticonvulsants with chemotherapeutic agents, tyrosine kinase inhibitors and glucocorticoids
2015
Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutations
2004 StandoutNobel
Management of glioblastoma: State of the art and future directions
2020 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
2018 Standout
Phase II Study of Donepezil in Irradiated Brain Tumor Patients: Effect on Cognitive Function, Mood, and Quality of Life
2006
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
2004 Standout
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair–deficient malignant glioma xenograft
2005 StandoutNobel
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
2021 Standout
Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed Oligoastrocytomas
2000
The epidemiology of glioma in adults: a "state of the science" review
2014 Standout
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
2016 Standout
Phase II Trial of Procarbazine, Lomustine, and Vincristine as Initial Therapy for Patients With Low-Grade Oligodendroglioma or Oligoastrocytoma: Efficacy and Associations With Chromosomal Abnormalities
2003
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018
2021 Standout
Cognitive Rehabilitation in Patients With Gliomas: A Randomized, Controlled Trial
2009
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
2008 Standout
Epigenome scans and cancer genome sequencing converge on WNK2 , a kinase-independent suppressor of cell growth
2007
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2019 Standout
Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas
2008
Incorporating Advances in Molecular Pathology Into Brain Tumor Diagnostics
2018
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Quantitative Imaging Study of Extent of Surgical Resection and Prognosis of Malignant Astrocytomas
1997
Stereotactic laser ablation of high-grade gliomas
2014
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
2007 Standout
Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma
2002
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
2009 Standout
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Role and Relevance of Neurocognitive Assessment in Clinical Trials of Patients With CNS Tumors
2006
Biomarkers in tumors of the central nervous system – a review
2019
Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions
2004
Prognostic Factors for Survival in Adult Patients With Recurrent Glioma Enrolled Onto the New Approaches to Brain Tumor Therapy CNS Consortium Phase I and II Clinical Trials
2007
An extent of resection threshold for newly diagnosed glioblastomas
2011 Standout
Review on Quality of Life Issues in Patients with Primary Brain Tumors
2010
Works of Robert M. Arusell being referenced
A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma
2006
A Prospective Study of Quality of Life in Adults With Newly Diagnosed High-Grade Gliomas
2008
Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma
2004
Validation of EORTC Prognostic Factors for Adults With Low-Grade Glioma: A Report Using Intergroup 86-72-51
2011
Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma.
1993
Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trial
2004
Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer
2004
Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas
2005
Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM
2010
Cognitive function after radiotherapy for supratentorial low-grade glioma: A North Central Cancer Treatment Group prospective study
2005
Neurocognitive function after radiotherapy (RT) for supratentorial low-grade gliomas (LGG): results of a north central cancer treatment group (NCCTG) prospective study
2003
A Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas: The Impact of the Extent of Resection on Quality of Life and Survival
2005
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
2008
Prospective Randomized Trial of Low- Versus High-Dose Radiation Therapy in Adults With Supratentorial Low-Grade Glioma: Initial Report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group Study
2002
Effects of Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma Measured by the Folstein Mini-Mental State Examination
2003